SCHEMBL30168746

SCHEMBL30168746

CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C

nearest known ligand 0.63

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ VIPR2 P41587 6/20 0.57
▸ VIPR1 P32241 4/20 0.56
▸ PTH1R Q03431 3/20 0.55
▸ GLP1R P43220 5/20 0.54
▸ CCKBR P32239 1/20 0.54
▸ TFPI P10646 1/20 0.54
▸ RXFP1 Q9HBX9 1/20 0.53
▸ GCGR P47871 1/20 0.52
▸ GIPR P48546 1/20 0.52
▸ ECE1 P42892 1/20 0.52
▸ MUS81 Q96NY9 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29836350 0.98 VIPR2 (0.57) VIPR2VIPR1PTH1RGLP1RCCKBR
SCHEMBL30168745 0.96 VIPR2 (0.58) VIPR2VIPR1PTH1RGLP1RCCKBR
SCHEMBL30168725 0.94 VIPR2 (0.61) VIPR2VIPR1GLP1RCCKBRGCGR
SCHEMBL30168738 0.94 VIPR1 (0.60) VIPR2VIPR1PTH1RGLP1RCCKBR
SCHEMBL29836299 0.93 VIPR2 (0.58) VIPR2VIPR1PTH1RGLP1RCCKBR
SCHEMBL30168684 0.93 VIPR1 (0.60) VIPR2VIPR1PTH1RGLP1RCCKBR
SCHEMBL30168686 0.93 VIPR2 (0.56) VIPR2VIPR1PTH1RGLP1RCCKBR
SCHEMBL30168733 0.93 VIPR2 (0.57) VIPR2VIPR1PTH1RGLP1RCCKBR
SCHEMBL29836409 0.91 VIPR1 (0.60) VIPR2VIPR1PTH1RGLP1RCCKBR
SCHEMBL29836388 0.91 VIPR2 (0.61) VIPR2VIPR1GLP1RCCKBRGCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12428638-B2 Three-component CRISPR/Cas complex system and uses thereof THE JACKSON LABORATORY (US) 2025-09-30 — — US disclosed
US-20230071712-A1 THREE-COMPONENT CRISPR/CAS COMPLEX SYSTEM AND USES THEREOF THE JACKSON LABORATORY (US) 2023-03-09 — — US disclosed
Send feedback